We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GSK, EMBL-EBI and Sanger Institute Launch Target Validation Initiative

News   Mar 27, 2014

 
GSK, EMBL-EBI and Sanger Institute Launch Target Validation Initiative
 
 
 

RELATED ARTICLES

Widely Available Antibiotics Could Be Used to Treat “Superbug” MRSA

News

Some MRSA infections could be tackled using widely-available antibiotics, suggests new research. A team of scientists used genome sequencing technology to identify which genes make MRSA susceptible to a previously defined combination of drugs. They identified a number of mutations centered around a protein known as a penicillin-binding protein 2a or PBP2a.

READ MORE

Keeping Kids Safe In the "Internet of Things" Era

News

Children need protection when using programmable Internet computing devices – and Lancaster University scientists have drawn up new guidelines to help designers build in safeguards.

READ MORE

Protein Stability Influences Stem Cell State

News

Protein stabilization has been implicated as a major factor in maintaining control of the stem cell state.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE